Recent Welsh lab Publications:

Research Papers:

  • ​Milani C, Katayama M, Carneiro de Lyra J,  Welsh JE, Campos L, Brentani M, Maciel M, Roela R, del Valle PR,  Góes J, Folgueira M (2013) Transcriptional effects of 1,25 dihydroxyvitamin D3 physiological and supra-physiological concentrations in breast cancer organotypic culture. BMC Cancer  13:119
  • Narvaez CJ, Simmons KM, Brunton J, Salinero A, Chittur SV and Welsh JE (2013) Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J Cellular Physiology  228:2024-2036
  • Wang WL, Welsh JE and Tenniswood M (2013) 1,25-Dihydroxyvitamin D(3) modulates lipid metabolism in prostate cancer cells through miRNA mediated regulation of PPARA.  J Steroid Biochem Mol Biol 136:247-251
  • Bikle DD, Elalieh H, Welsh JE, Oh D, Cleaver J and Teichert A (2013)   Protective role of vitamin D signaling in skin cancer formation. J Steroid Biochem Mol Biol 136:271-279
  • Keith M, LaPorta E and Welsh JE (2013) Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.  Mol Carc 53:286-299
  • Rhieu SY, Annalora AJ, Laporta E, Welsh J, Itoh T, Yamamoto K, Sakaki T, Chen TC, Uskokovic MR and Reddy GS (2014) Potent antiproliferative effects of 25-Hydroxy-16-ene-23-yne-vitamin D3 that resists the catalytic activity of both CYP27B1 and CYP24A1.  J Cell Biochem 115:1392-1402
  • LaPorta E and Welsh JE (2014) Modeling vitamin D actions in triple negative/basal-like breast cancer.    J Steroid Biochem Mol Biol 144:65-73
  • Helle J, Kräker K, Bader MK, Keiler AM, Zierau O,  Vollmer G,  Welsh J and Kretzschmar G (2014) Assessment of the proliferative capacity of the flavanones 8-Prenylnaringenin, 6-(1.1-dimethylallyl)naringenin and Naringenin in MCF-7 cells and the rat mammary gland. Mol Cell Endo 392:125-35
  • Beaudin S, Robilotto S and Welsh JE (2015) Comparative regulation of gene expression by 1,25-dihydroxyvitamin D3 in cells derived from normal mammary tissue and breast cancer. J Steroid Biochem Mol Biol 148:96-102
  • Simmons KM, Beaudin SG, Narvaez CJ and Welsh JE (2015) Gene signatures of 1,25-Dihydroxyvitamin D3 exposure in normal and transformed mammary cells. J Cell Biochem 116:1693-1711   
  • Matthews D, D’Angelo J, Drelich J and Welsh JE (2015)  Adipose-specific VDR deletion alters body fat and enhances mammary epithelial density.  J Steroid Biochem Mol Biol  164:299-308
  • Beaudin SG and Welsh JE (2016) 1,25-Dihydroxyvitamin D induces the glutamate transporter SLC1A1 and alters glutamate handling in non-transformed mammary cells. Mol Cell Endo 424:34-41
  • Alimirah F, Peng X, Gupta A, Yuan L, Welsh JE, Cleary M and Mehta R. Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells. Exp Res 349:15-22

Reviews and Chapters:

  • Narvaez CJ, Matthews D, LaPorta E, Simmons K,  Beaudin S and Welsh JE (2014) The impact of vitamin D in breast cancer: genomics, pathways, metabolism. Front Physiol. 5:213. doi: 10.3389/fphys.2014.00213
  • Welsh JE, Bikle DD and Lips P (2015) Highlights from the 17th Workshop on Vitamin D, Chicago, IL, June 17-21, 2014. J Steroid Biochem Mol Biol 148:1-2  
  • Welsh, JE  Modelling breast cancer in animals – considerations for prevention and treatment studies.  Chapter 35 in Animal Models of Disease, 2nd Edition. Conn M, editor. Elsevier, in press
  • Welsh, JE Vitamin D actions in mammary gland and breast cancer: genomics, metabolism and stem cells.  Chapter 98 in: Vitamin D. Fourth Edition.  Feldman D, Pike JW, Bouillon R, Giovannucci E, Goltzman D & Hewison M,  editors. Elsevier, in press
  • Welsh, JE Vitamin D, VDR and adipose tissue: focus on cellular mechanisms. Chapter 34 in: Vitamin D. Fourth Edition.  Feldman D, Pike JW, Bouillon R, Giovannucci E, Goltzman D & Hewison M,  editors. Elsevier, in press

View Dr. Welsh's NCBI Bibliography HERE

Welsh Lab - University at Albany